Health1 min read

The Drugs Don’t Work

By · Published by Everything Blog

In short

The rise of antimicrobial resistance poses a severe threat to global health, especially in sub-Saharan Africa where infant mortality is heavily impacted. While major pharmaceutical firms like GlaxoSmithKline encounter difficulties developing novel treatments, British universities and hospitals are pursuing advanced scientific solutions. These researchers are collaborating with the UK tech firm DeepMind to identify new therapeutic pathways. Bridging these high-tech efforts with localized African innovations is essential to preventing millions of fatalities.

Key points

  • Commercial pharmaceutical companies face significant hurdles when attempting to develop n…: Commercial pharmaceutical companies face significant hurdles when attempting to develop novel antibiotic treatments.
  • Healthcare providers in the developing world frequently depend on low-tech solutions to m…: Healthcare providers in the developing world frequently depend on low-tech solutions to manage drug-resistant illnesses.
  • Combining local innovations in Africa with resources from developed nations is vital for…: Combining local innovations in Africa with resources from developed nations is vital for saving lives worldwide.

Sources checked by our analysis pipeline: 1

Featured Documentaries

The Drugs Don’t Work

A look at how antibiotic overuse could fuel superbugs, killing eight million people annually by 2050.

The challenges posed by antimicrobial resistance show where its impact is most acutely and tragically manifested: infant mortality in the developing world, specifically in sub-Saharan Africa. This film shows what these bland statistics mean in real terms to the health workers and families affected, following them as they struggle to fight this battle with low-tech solutions.

The Drugs Don’t Work follows the battle to the United Kingdom and examines how and why penicillin, the world’s most successful antibiotic, was invented. It then examines why pharmaceutical companies like GlaxoSmithKline are struggling to produce novel solutions to the problem of antimicrobial resistance (AMR).

The film also explores the cutting edge of academic research at British universities and hospitals supported by the power of the UK-based tech company DeepMind, and features academics and advocates who are devoting their lives to solving the problem. Returning to Africa, it shows how local innovation and the tools offered by the developed world are now…

Health